结直肠癌临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 结直肠癌（国际通用名 colorectal cancer）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肠癌、大肠癌、结肠癌、直肠癌等说法。

正在招募的结直肠癌新药试验

• Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

  II 期招募中中国NCT06540326

• Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

  不适用招募中美国NCT07254910

• SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer

  II 期招募中中国NCT07162714

• E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

  II 期招募中美国NCT05686226

• Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

  II 期招募中美国NCT06848348

• The Development of MASLD Among Survivors of Breast or Colorectal Cancer

  不适用招募中SwitzerlandNCT07280143

• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  I 期 / II 期招募中美国日本NCT07488676

• Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

  I 期招募中LebanonNCT06307249

• Cadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer

  III 期招募中中国NCT06566755

• The Impact of Laparotomy and Analgesia Methods on Diaphragm

  不适用招募中Turkey (Türkiye)NCT06403540

• PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer

  III 期招募中中国NCT05236972

• Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

  I 期招募中美国NCT05803382